Suicidality among users of glucagon-like peptide-1 receptor agonists: an emerging signal
Pyridoxine (Vitamin B6) - Pregnancy and Breastfeeding Warnings
A potential candidate may: Have gradual thinning rather than a smooth area without follicles Want to support scalp and follicle condition Experience fragile hair or repeated breakage Be interested in complementary hair-restoration care Understand that evidence varies between peptides Be willing to use a product consistently for several months Have concerning causes of shedding evaluated A medical evaluation should come first when hair loss is sudden, painful, patchy, rapidly progressing, or accompanied by scaling, sores, inflammation, or other health changes
Evidence based on recent studies Initially, cases of intestinal obstruction associated with GLP-1 RAs were reported by the European Medicines Agency (EMA) in 2013 [9], and this safety signal is currently being monitored by the United States (US) FDA
However, the specific mechanism of fibrogenic factor secretion during ferroptosis in renal tubular epithelial cells remains unclear
